![]() |
The UK MHRA plans to let drugmakers import APIs that lack ‘written confirmation’ of quality if there is an overriding need to ensure continued supply. Related news |
Shasun Pharmaceuticals’ says it is trying to restart operations at the earliest opportunity after workers went on strike at its API and formulation facility in India last Sunday.
Teva has affirmed its respiratory drug delivery strategy with the purchase of MicroDose Therapeutx for a potential $165m (€123m).
A GlaxoSmithKline subsidiary has issued a recall of two batches of Ventolin syrup in the UK after glass fragments were found in some bottles.
Manufacturers’ quality issues were among the most prevalent reasons for drug shortages, according to a new industry survey.
CRO Parexel’s massive backlog could position the company for continued revenue growth moving forward, top executives said at recent conferences.
MPI Research, inviCRO and 3D Imaging are partnering to combine their imaging tools at a new center in Michigan aimed at large biopharma clients.
A US CMO that promised to make cost-effective, generic insulin has been sued by the city where it planned to set up a manufacturing plant.
Logistics company DHL has launched a new temperature controlled air freight service to service for biologics.
Bioclinica has partnered with a Chinese hospital citing growing regulatory pressure for cardiac safety studies in the country as the key driver.
BioPharm America™ 2013—6th Annual International Partnering Conference
Boston, MA, USA / Conference